Élodie Bouaziz-Amar

Quantifying prion disease penetrance using large population control cohorts

Eric Vallabh Minikel, Sonia M. Vallabh, Monkol Lek et al. · Science Translational Medicine · 2016 · 469 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Annika Öhrfelt, Ann Brinkmalm, Julien Dumurgier et al. · Alzheimer s Research & Therapy · 2016 · 192 citations · Full text

Medicine, Neurology, Neuroscience +17

Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology

Charles Duyckaerts, Véronique Sazdovitch, Kunié Ando et al. · Acta Neuropathologica · 2017 · 80 citations

Life Sciences, Neurology, Neuroscience +12

Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

Emma Jones, Holger Hummerich, Emmanuelle Viré et al. · The Lancet Neurology · 2020 · 77 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study

Hana Saddiki, Aurore Fayossé, Emmanuel Cognat et al. · PLoS Medicine · 2020 · 76 citations · Full text

Medicine, Genetics, Neurology +17